Daniel Joseph Oconnell
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $163K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 23SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 9,346883,964 held (−1%) | $1.81 | $17K | +18.2% |
| Jan 23SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 2,689881,275 held (−0%) | $1.88 | $5K | +13.8% |
| Jan 12SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 8,143611,839 held (−1%) | $1.82 | $15K | +17.6% |
| Jan 12SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 12,941598,898 held (−2%) | $1.76 | $23K | +21.6% |
| Jan 12SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 5,388593,510 held (−1%) | $1.73 | $9K | +23.7% |
| Jan 7SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 4,649662,839 held (−1%) | $1.97 | $9K | +8.6% |
| Jan 7SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 5,102657,737 held (−1%) | $1.97 | $10K | +8.6% |
| Jan 7SEC | ABOSAcumen Pharmaceuticals, Inc. | Sell Plan | 37,755619,982 held (−6%) | $1.99 | $75K | +7.5% |
- Sell
CEO Daniel Joseph Oconnell sold $17K of ABOS at $1.81 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Daniel Joseph Oconnell sold $5K of ABOS at $1.88 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Daniel Joseph Oconnell sold $15K of ABOS at $1.82 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Daniel Joseph Oconnell sold $23K of ABOS at $1.76 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Daniel Joseph Oconnell sold $9K of ABOS at $1.73 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Daniel Joseph Oconnell sold $9K of ABOS at $1.97 — pre-scheduled 10b5-1 plan sale.